Solicitation of the Nomination of Candidates To Serve as Members of the National Vaccine Advisory Committee, 49620-49621 [05-16762]
Download as PDF
49620
Federal Register / Vol. 70, No. 163 / Wednesday, August 24, 2005 / Notices
Trans #
Acquiring
Acquired
Entities
Transactions Granted Early Termination—08/03/2005
20051341 .........................
Department 56, Inc ............................
Brown-Forman Corporation ...............
Lenox, Incorporated.
Transactions Granted Early Termination—08/04/2005
20051253 .........................
20051268 .........................
Integrated Device Technology, Inc ...
Entergy Corporation ..........................
Integrated Circuit Systems, Inc .........
Attala 2004 Trust ...............................
20051303 .........................
20051316 .........................
Omnicare, Inc ....................................
New Refco Group Ltd., LLC ..............
excelleRx, Inc ....................................
Cargill Incorporated ...........................
Integrated Circuit Systems, Inc.
Central Mississippi Generating Company, LLC
excelleRx, Inc.
Cargill Investor Services, Inc., Cargill
Investor Services Limited, Cargill
Investor Services (Singapore) Pte.
Ltd., CIS Cash Management, Inc.,
CIS Financial Services, Inc., CIS
Investments, Inc., CIS Securities,
Inc.
Transactions Granted Early Termination—08/05/2005
20051308
20051329
20051330
20051336
.........................
.........................
.........................
.........................
Cemex S.A. de C.V. ..........................
Stefan Pierer .....................................
Rudolf Knunz .....................................
Pharma Services Holding, Inc ...........
20051337 .........................
20051344 .........................
20051346 .........................
Greene Group, Inc ............................
Polaris Industries Inc .........................
Polaris Industries Inc .........................
Welsch, Carson, Anderson & Stowe
X, L.P.
WMB Holdings Inc .............................
Perot Systems Corporation ...............
Sagicor Financial Corporation ...........
20051349 .........................
20051353 .........................
20051358 .........................
Cisco Systems, Inc ............................
BNP Paribas S.A ...............................
Fiserv, Inc ..........................................
20051364 .........................
20051368 .........................
Business Objects S.A ........................
Barry Diller .........................................
Sheer Networks Inc ...........................
FundQuest Incorporated ...................
Great Hill Equity Partners II Limited
Partnership.
Trevor Lloyd ......................................
Barry Diller .........................................
For Further Information Contact:
Sandra M. Peay, Contact Representative
or Renee Hallman, Case Management
Assistant. Federal Trade Commission,
Premerger Notification Office, Bureau of
Competition, Room H–303, Washington,
DC 20580, (202) 326–3100.
By Direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 05–16778 Filed 8–23–05; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of the Nomination of
Candidates To Serve as Members of
the National Vaccine Advisory
Committee
AGENCY: Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
Authority: 42 U.S.C. 300aa–5, Section 2105
of the Public Health Service (PHS) Act, as
amended. The Committee is governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which sets
VerDate jul<14>2003
15:23 Aug 23, 2005
Jkt 205001
CityBank ............................................
Ronald J. Lockard .............................
Vesta Insurance Group, Inc ..............
forth standards for the formation and use of
advisory committees.
SUMMARY: The National Vaccine
Program Office (NVPO), a program
office within the Office of Public Health
and Science, DHHS, is soliciting
nominations of qualified candidates to
be considered for appointment as
members and representatives to the
National Vaccine Advisory Committee
(NVAC). The activities of this
Committee are governed by the Federal
Advisory Committee Act (FACA).
Consistent with the National Vaccine
Plan, the Committee advises and makes
recommendations to the Assistant
Secretary for Health in his/her capacity
as the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities. Specifically,
the Committee studies and recommends
ways to encourage the availability of an
adequate supply of safe and effective
vaccination products in the United
States; recommends research priorities
and other measures to enhance the
safety and efficacy of vaccines. The
Committee also advises the Assistant
Secretary for Health in the
implementation of Sections 2102 and
2103 of the PHS Act; and identifies
annually the most important areas of
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
RMC Mid-Atlantic, LLC.
KTM Power Sports AG
KTM Power Sports AG.
Early Development and Packaging
Services, USA, L.L.C.
Diligenz, Inc.
Technical Management, Inc.
American Founders Financial Corporation, Laurel Life Insurance
Company.
Sheer Networks Inc.
FundQuest Incorporated.
BillMatrix Corporation.
SRC Software, Inc.
Expedia, Inc.
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: Nominations for membership on
the Committee must be received no later
than 5 p.m. EST on October 3, 2005, at
the address below.
ADDRESSES: All nominations should be
mailed or delivered to Bruce G. Gellin,
M.D., M.P.H., Executive Secretary,
National Vaccine Advisory Committee,
Office of Public Health and Science,
Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 443–H, Hubert H. Humphrey
Building; Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms.
Emma English, Program Analyst,
National Vaccine Program Office,
Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 443–H, Hubert H. Humphrey
Building, Washington, DC 20201; (202)
690–5566; nvac@osophs.dhhs.gov.
A copy of the Committee charter and
list of the current membership can be
obtained by contacting Ms. English or
by accessing the NVAC Web site at:
https://www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\24AUN1.SGM
24AUN1
Federal Register / Vol. 70, No. 163 / Wednesday, August 24, 2005 / Notices
Committee Function: Qualifications
and Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
Committee. Individuals selected for
appointment to the Committee will
serve as voting members or
representatives. Voting members shall
be selected from individuals who are
engaged in vaccine research or the
manufacture of vaccines, or who are
physicians, members of parent
organizations concerned with
immunizations, representatives of State
or local health agencies or public health
organizations. Voting representatives are
official representatives of the vaccine
manufacturing industry who are
engaged in vaccine research or the
manufacture of vaccines. Individuals
selected for appointment to the
Committee can be invited to serve terms
with periods of up to four years.
Nominations should be typewritten.
The following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity), and a statement
that the nominee is willing to serve as
a member of the Committee; (2) the
nominator’s name, address and daytime
telephone number, and the home and/
or work address, telephone number, and
email address of the individual being
nominated; and (3) a current copy of the
nominee’s curriculum vitae.
Applications cannot be submitted by
facsimile. The names of Federal
employees should not be nominated for
consideration of appointment to this
Committee.
The Department makes every effort to
ensure that the membership of HHS
Federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made that a
broad representation of geographic
areas, gender, ethnic and minority
groups, and the disabled are given
consideration for membership on HHS
Federal advisory committees.
Appointment to this committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
VerDate jul<14>2003
15:23 Aug 23, 2005
Jkt 205001
Dated: August 18, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05–16762 Filed 8–23–05; 8:45 am]
BILLING CODE 4150–44–P
49621
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–05–0106]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration on Aging
2005 White House Conference on
Aging Policy Committee
AGENCY: Administration on Aging, HHS.
ACTION: Notice of meeting.
SUMMARY: Pursuant to Section 10(a) of
the Federal Advisory Committee Act as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the seventh Policy
Committee meeting concerning
planning for the 2005 White House
Conference on Aging. The meeting will
be open to the public, with attendance
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should inform the
contact person listed below in advance
of the meeting.
DATES: The meeting will be held
Tuesday, September 20, 2005, from 10
a.m. to 4:30 p.m.
ADDRESSES: The meeting will be held in
the Atrium Ballroom at The Washington
Court Hotel, 525 New Jersey Avenue,
NW., Washington, DC 20001–1527.
FOR FURTHER INFORMATION CONTACT: Kim
Butcher at (301) 443–2887, or e-mail at
Kim.Butcher@whcoa.gov. Registration is
not required. Seating is on a first come,
first-served basis.
SUPPLEMENTARY INFORMATION: Pursuant
to the Older Americans Act
Amendments of 2000 (Pub. L. 106–501,
November 2000), the Policy Committee
will meet to continue discussions and
planning for the 2005 WHCoA that will
be held from December 11 through 14,
2005. In addition, there will be
presentations by Brent Green, President
of Brent Green & Associates, Inc., a
marketing consulting firm, and author of
Marketing to Leading Edge Baby
Boomers and David G. Walker,
Comptroller General, U.S. Government
Accountability Office.
Dated: August 19, 2005.
Edwin L. Walker,
Deputy Assistant Secretary for Policy and
Programs.
[FR Doc. 05–16829 Filed 8–23–05; 8:45 am]
BILLING CODE 4154–01–P
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 371–5983 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Preventive Health and Health Services
Block Grant, Annual Application and
Reports, OMB No. 0920–0106—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In 1994, OMB approved the collection
of information provided in the grant
applications and annual reports for the
Preventive Health and Health Services
(PHHS) Block Grant (OMB No. 0920–
0106). CDC is requesting OMB clearance
for this legislatively mandated
information collection. The request is to
approve the development and
adherence to Healthy People 2010 (the
Nation’s Health Objectives) which was
released in the Spring of 2000. The
PHHS block grant is mandated
according to section 1904 to adhere to
the Healthy People framework.
This information, which is collected
through the application forms from the
official State health agencies, is required
from section 1905 of the Public Health
Service Act. There is a slight change in
the proposed information collection
from previous years. The changes
include more program specific
information and the relationship of
block funded activities to program
strategy. The information collected from
the annual report forms is required by
section 1906. The development of a
PHHS block grant Web page, with data
Web links from existing federal
databases, will be used to coincide with
the collection of uniform data for the
E:\FR\FM\24AUN1.SGM
24AUN1
Agencies
[Federal Register Volume 70, Number 163 (Wednesday, August 24, 2005)]
[Notices]
[Pages 49620-49621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16762]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of the Nomination of Candidates To Serve as Members
of the National Vaccine Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health
Service (PHS) Act, as amended. The Committee is governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2),
which sets forth standards for the formation and use of advisory
committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of Public Health and Science, DHHS, is soliciting
nominations of qualified candidates to be considered for appointment as
members and representatives to the National Vaccine Advisory Committee
(NVAC). The activities of this Committee are governed by the Federal
Advisory Committee Act (FACA).
Consistent with the National Vaccine Plan, the Committee advises
and makes recommendations to the Assistant Secretary for Health in his/
her capacity as the Director of the National Vaccine Program, on
matters related to the Program's responsibilities. Specifically, the
Committee studies and recommends ways to encourage the availability of
an adequate supply of safe and effective vaccination products in the
United States; recommends research priorities and other measures to
enhance the safety and efficacy of vaccines. The Committee also advises
the Assistant Secretary for Health in the implementation of Sections
2102 and 2103 of the PHS Act; and identifies annually the most
important areas of government and non-government cooperation that
should be considered in implementing Sections 2102 and 2103 of the PHS
Act.
DATES: Nominations for membership on the Committee must be received no
later than 5 p.m. EST on October 3, 2005, at the address below.
ADDRESSES: All nominations should be mailed or delivered to Bruce G.
Gellin, M.D., M.P.H., Executive Secretary, National Vaccine Advisory
Committee, Office of Public Health and Science, Department of Health
and Human Services, 200 Independence Avenue, SW., Room 443-H, Hubert H.
Humphrey Building; Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst,
National Vaccine Program Office, Department of Health and Human
Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. Humphrey
Building, Washington, DC 20201; (202) 690-5566; nvac@osophs.dhhs.gov.
A copy of the Committee charter and list of the current membership
can be obtained by contacting Ms. English or by accessing the NVAC Web
site at: https://www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION:
[[Page 49621]]
Committee Function: Qualifications and Information Required: As
part of an ongoing effort to enhance deliberations and discussions with
the public on vaccine and immunization policy, nominations are being
sought for interested individuals to serve on the Committee.
Individuals selected for appointment to the Committee will serve as
voting members or representatives. Voting members shall be selected
from individuals who are engaged in vaccine research or the manufacture
of vaccines, or who are physicians, members of parent organizations
concerned with immunizations, representatives of State or local health
agencies or public health organizations. Voting representatives are
official representatives of the vaccine manufacturing industry who are
engaged in vaccine research or the manufacture of vaccines. Individuals
selected for appointment to the Committee can be invited to serve terms
with periods of up to four years.
Nominations should be typewritten. The following information should
be included in the package of material submitted for each individual
being nominated for consideration: (1) A letter of nomination that
clearly states the name and affiliation of the nominee, the basis for
the nomination (i.e., specific attributes which qualify the nominee for
service in this capacity), and a statement that the nominee is willing
to serve as a member of the Committee; (2) the nominator's name,
address and daytime telephone number, and the home and/or work address,
telephone number, and email address of the individual being nominated;
and (3) a current copy of the nominee's curriculum vitae. Applications
cannot be submitted by facsimile. The names of Federal employees should
not be nominated for consideration of appointment to this Committee.
The Department makes every effort to ensure that the membership of
HHS Federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
that a broad representation of geographic areas, gender, ethnic and
minority groups, and the disabled are given consideration for
membership on HHS Federal advisory committees. Appointment to this
committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
Dated: August 18, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-16762 Filed 8-23-05; 8:45 am]
BILLING CODE 4150-44-P